Effect of esketamine combined with pregabalin on acute postsurgical pain in patients who underwent resection of spinal neoplasms: a randomized controlled trial

医学 普瑞巴林 随机对照试验 麻醉 入射(几何) 不利影响 安慰剂 可视模拟标度 生理盐水 氯胺酮 外科 内科学 物理 替代医学 病理 光学
作者
Yang Zhou,Wanchen Sun,Yuxuan Fu,Jing Wang,Jingyi Fan,Yuchao Liang,Wenqing Jia,Ruquan Han
出处
期刊:Pain [Lippincott Williams & Wilkins]
卷期号:165 (9): e96-e105 被引量:8
标识
DOI:10.1097/j.pain.0000000000003211
摘要

Moderate-to-severe acute postsurgical pain (APSP) can prolong the recovery and worsen the prognosis of patients who undergo spinal surgery. Esketamine and pregabalin may resolve APSP without causing hyperpathia or respiratory depression after surgery. However, there are other risks, such as dissociative symptoms. We designed a randomized controlled trial to investigate the effect of the combination of these 2 drugs on the incidence of APSP in patients who underwent resection of spinal neoplasms. Patients aged 18 to 65 years were randomized to receive esketamine (a bolus dose of 0.5 mg·kg -1 and an infusion dose of 0.12 mg·kg -1 ·h -1 for 48 hours after surgery) combined with oral pregabalin (75-150 mg/day, starting 2 hours before surgery and ending at 2 weeks after surgery) or an identical volume of normal saline and placebo capsules. The primary outcome was the proportion of patients with moderate-to-severe APSP (visual analog scale score ≥ 40) during the first 48 hours after surgery. Secondary outcomes included the incidence of drug-related adverse events. A total of 90 patients were randomized. The incidence of moderate-to-severe APSP in the combined group (27.3%) was lower than that in the control group (60.5%) during the first 48 hours after surgery (odds ratio = 0.25, 95% CI = 0.10-0.61; P = 0.002). The occurrence of mild dissociative symptoms was higher in the combined group than in the control group (18.2% vs 0%). In conclusion, esketamine combined with pregabalin could effectively alleviate APSP after spinal surgery, but an analgesic strategy might increase the risk of mild dissociative symptoms.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
多晒太阳关注了科研通微信公众号
刚刚
刚刚
sss完成签到,获得积分10
1秒前
liaos完成签到 ,获得积分10
1秒前
1秒前
1秒前
醉熏的嫣然完成签到,获得积分20
1秒前
VV关注了科研通微信公众号
2秒前
2秒前
喂鼠馍完成签到 ,获得积分10
2秒前
F_ken发布了新的文献求助10
2秒前
3秒前
wyyyy发布了新的文献求助10
3秒前
if的应助被candiceli采纳,获得20
3秒前
Owen的应助被伶俐的老头采纳,获得10
3秒前
Yacoob完成签到,获得积分10
3秒前
4秒前
liu发布了新的文献求助30
4秒前
完美世界的应助被xinyang采纳,获得10
5秒前
ljf驳回了wanci的应助
5秒前
嘟嘟完成签到,获得积分10
5秒前
SciGPT的应助被阿戈美拉丁采纳,获得10
5秒前
随风完成签到,获得积分20
7秒前
Li完成签到 ,获得积分10
7秒前
大个的应助被xzl123采纳,获得10
8秒前
9秒前
9秒前
ZGD完成签到 ,获得积分10
10秒前
桃子发布了新的文献求助10
11秒前
west完成签到,获得积分10
11秒前
徐师傅完成签到,获得积分10
11秒前
小二郎的应助被312采纳,获得10
13秒前
大模型的应助被so采纳,获得10
13秒前
13秒前
章鱼小丸子完成签到 ,获得积分10
14秒前
14秒前
左旋多巴完成签到,获得积分0
14秒前
qwzh完成签到,获得积分10
14秒前
水煮电吹风的应助被hc采纳,获得10
14秒前
lydia完成签到,获得积分10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8182147
求助须知:如何正确求助?哪些是违规求助? 9571790
关于积分的说明 21820037
捐赠科研通 7778601
什么是DOI,文献DOI怎么找? 3433617
关于科研通互助平台的介绍 2557786
邀请新用户注册赠送积分活动 2479652